Aspivix

😊 Smiles speak volumes about excitement!! 😊 Last week, our CTO and co-founder, Julien FINCI, delivered an amazing training session with Bayer AG Schweiz to a group of enthusiastic OBGYNs interns from the Luzerner Kantonsspital. Sarina Schneider - Meier | Muriel Eugster - Disler, Dr. med. | Kevin Brunold | Romana Dolinschek | Dr. med. Sofie Hirvonen | Mirjam Franzelli The interns' enthusiasm was contagious, and their smiles spoke volumes about their passion for their work and excitement using the #carevix. So inspiring to see such dedication and commitment from the next generation of healthcare professionals in gynecology motivated to improve women's care. To all game-changers, let's continue making #gynecology now modern! ♀ See you at the upcoming Swiss Society for Gynecology and Obstetric conference (#SGGG) in Interlaken, Switzerland June 27-28! #OBGYN #WomensHealth #contraception #FemTech #reproductivehealth

🌟 Advancing Women's Health with Carevix at Cemicamp in Campinas, Brazil 🇧🇷 🌟 Last week, our CTO Julien FINCI had the incredible opportunity to conduct a training session on our innovative #Carevix device at the University of Campinas, Cemicamp, in Brazil 🇧🇷 . This session was a significant step in our mission to gather real-world data on Carevix's usage in LATAM, and we're thrilled to add Cemicamp as an Ambassador site. Thanks to Prof. Luis Bahamondes and Bayer | Pharmaceuticals thousands of women can access safe contraception in low and middle-income countries #LMIC It was a pleasure to work with: - Prof. Dr. Luis Bahamondes - Dr. Ana Claudia Henrique Marcelino - Ximena Espejo-Arce, Midwife - Paula da Cunha Pereira, Clinical Research Assistant, Nurse - Vilma Zotarelli, Administration Their dedication and expertise in the field of family planning and gynecology are truly inspiring. Together, we're paving the way for safer and more effective women's health solutions. Our collaboration aims to enhance #data collection in real-life settings, ensuring that #Carevix continues to meet the needs of healthcare professionals and patients alike. The enthusiasm and commitment shown by the team at Cemicamp were truly remarkable, and we are confident that our partnership will yield invaluable insights. Stay tuned as we continue to expand our network of Ambassador sites and drive forward innovation in gynecology. Let's keep pushing the boundaries of women's healthcare! 🌸 #Aspivix #Carevix #WomensHealth #Gynecology #Innovation #RealWorldData #MedicalTechnology #FemTech #Cemicamp #Brazil Luis Bahamondes Julien FINCI

💡 Did you know that according to United Nations figures indicate that 80% of people displaced by climate change are women? So how can we address this issue and ensure that women are not disproportionately affected by climate change? 💪 Aspivix is committed to contributing to the UN SDG goal #15 by providing innovative suction-based technology with #carevix that received the “financial climate contribution” label. Together with ClimatePartner: 📝 We collaborate to document the carbon emissions of the production of our product carevix we compensate for. 📉 We’re addressing concerns around carbon emissions by reducing them whenever possible from the production to our team’s way of working and counterbalance them by financing certified climate protection projects. 🌏 We support climate projects to fill the urgent financing gap, especially in countries of the Global South. ♻ We are transparent as we enable our customers to track this funding and learn more about the climate project we are supporting by using the "Financial climate contribution" label. This financial support is urgent and necessary because we need to take climate action now and Aspivix is proud to be part of this initiative. 🚺 So as a company focused on making women’s health modern, safe, and beneficial for women, why would we do it in such a way as to add to climate change during the manufacturing process of the Carevix? Our goal is not only to make gynecology modern by supporting women through but also to make sure that we don’t add to climate change. We do not want to hurt the people in the process of trying to help them. 🎯 By 2030, our goal is clear: Ensure sustainable consumption and production patterns by enhancing patient care experience and empowering people worldwide. #Climate #ReproductiveHealth #Innovation #GlobalGoals #HealthcareRevolution #Femtech #unsdgs #womenshealth

Ever wondered if there's a better way to approach gynecological procedures than the traditional tenaculum? 🤔 We have took initiative and innovated with your comfort in mind.🌸 The traditional 135 year-old tenaculum, while effective most of the time, causes discomfort and trauma. Our innovation, #Carevix™, changes the narrative by finally prioritizing patient experience and comfort by reducing procedure-related pain.💗 Imagine a gynecological visit where pain is minimized and trauma is reduced. With Carevix™, we're enhancing patient experiences and empowering women to prioritize their health without fear of discomfort.🌟 Let's pave the way for gentler, more compassionate gynecological procedures together. 🤝 Learn more about Carevix™ and our commitment to innovation and patient care. ➡️ www.aspivix.com #WomensHealth #PatientCare #Gynecology #HealthcareInnovation #PatientComfort #MedicalAdvancements #Aspivix #FemTech #iud

🌟Aspivix selected for the Swiss innovation China Roadshow 2024!🌟 Our CEO, Mathieu Horras, had an incredible experience at the Swiss Innovation China Roadshow 2024, which took place from June 21st to June 29th in 4 key cities: Shanghai, Hangzhou, Suzhou, and Beijing. This dedicated program for Swiss entrepreneurs was a fantastic opportunity for us to explore local opportunities and support fundraising efforts in China. We are immensely grateful for the warm welcome and the valuable connections we made. A pitch competition concluded the last day of this roadshow. Fingers crossed for the final results of the competition in the upcoming weeks! 🤞 A huge thank you to everyone who attended and engaged with us during the roadshow. Your support in Aspivix and our mission, 'Gynecology. Now Modern,' are deeply appreciated. We also extend our sincere thanks to the organizers for allowing us to be part of this remarkable event. Stay tuned as we continue to drive innovation in women's health and make a difference globally. 🌍✨ Switzerland Innovation Tech4Eva - The global Femtech accelerator Biopôle Lausanne #Aspivix #SwissInnovation #ChinaRoadshow2024 #GynecologyNowModern #Innovation #Fundraising

🌟 Reflecting on the SGGG Swiss Conference 2024: A Heartfelt Thank You 🌟 As the annual conference SGGG 2024 in Interlaken comes to an end, we are overwhelmed with gratitude for everyone who joined us on this incredible journey. To each attendee, speaker, and exhibitor, thank you for being a part of this year’s SGGG Swiss Conference. Your participation and excitement made it truly special. A special thank you goes to: 🌸 Dr. Michal Yaron from the HUG - Hopitaux Universitaires de Genève. We deeply appreciate her sharing the findings from real-world data and her experience. 🌸 Bayer AG Schweiz for this exceptional opportunity to be by your side in a beautiful booth to present our innovation and a gentle solution in gynecology with your incredible women’s health team SGGG 2024 was more than just a conference—it was a unique opportunity for connection and collaboration. We're thrilled to have met over 100 individuals at our shared booth dedicated to improve women's care. See you soon in #Switzerland! 🌟 Sandrine Aeby Marco Gierten Moritz Holenstein Women's Health | Bayer plc WOMEN | Bayer #gynecology #swissinnovation #swisstech #iud #aspivix #carevix #cervix #womenshealth #femtech #medtech #medicaltechnology #femalemedicaltechnology Julien FINCI Ikram Guerd ---------------------------------------------------------------------------- 🌟 Rückblick auf die SGGG Swiss Conference 2024: Ein herzliches Dankeschön 🌟 Die Jahreskonferenz SGGG 2024 in Interlaken neigt sich dem Ende zu und wir sind überwältigt von Dankbarkeit für alle, die uns auf dieser unglaublichen Reise begleitet haben. Wir danken allen Teilnehmerinnen und Teilnehmern, Referentinnen und Referenten sowie Ausstellerinnen und Ausstellern, dass sie an der diesjährigen SGGG Swiss Conference teilgenommen haben. Ihre Teilnahme und Ihre Begeisterung haben die Konferenz zu etwas ganz Besonderem gemacht. Ein besonderes Dankeschön geht an: - Dr. Michal Yaron vom HUG - Hopitaux Universitaires de Genève. Wir schätzen es sehr, dass sie ihre Erkenntnisse aus der Praxis und ihre Erfahrungen mit uns geteilt hat. - Bayer AG Schweiz für diese aussergewöhnliche Gelegenheit, an einem wunderschönen Stand an Ihrer Seite zu sein und unsere Innovation und eine sanfte Lösung in der Gynäkologie mit Ihrem unglaublichen Frauengesundheitsteam zu präsentieren SGGG 2024 war mehr als nur eine Konferenz - es war eine einmalige Gelegenheit für Kontakte und Zusammenarbeit. Wir sind begeistert, dass wir über 100 Personen an unserem gemeinsamen Stand getroffen haben, die sich für die Verbesserung der Frauengesundheit einsetzen. Wir sehen uns bald in der Schweiz! 🌟

Join us in our Booth A5 to engage with our team, Julien FINCI and Ikram Guerd, at the SGGG Swiss Conference on June 27-28! Get ready for live demos, competition on simulators, and a glimpse into the future of gynecology! 🚀 🏆 Booth Competition & Simulator Access: Stop by our booth to participate in a friendly hands-on competition to master the #Carevix™ using simulators, offering interactive learning opportunities and get a chance to get a prize. 📅 Date: June 27-28, 2024 📍 Booth A5 📍 Location: Congress Centre Kursaal Interlaken, Switzerland 🔔 Follow us for updates and live coverage from the SGGG Annual Congress of Swiss Gynaecology. We look forward to seeing you there. 👋 Besuchen Sie uns an unserem Stand A5, um mit unserem Team, Julien FINCI und Ikram Guerd, an der SGGG Swiss Conference am 27. und 28. Juni in Kontakt zu treten! Machen Sie sich bereit für Live-Demos, Wettbewerbe an Simulatoren und einen Blick in die Zukunft der Gynäkologie! 🚀 🏆 Standwettbewerb & Simulatorzugang: Kommen Sie an unserem Stand vorbei und nehmen Sie an einem freundlichen praktischen Wettbewerb zur Beherrschung der #Carevix™ an Simulatoren teil, der interaktive Lernmöglichkeiten bietet und Ihnen die Chance auf einen Preis gibt. 📅 Termin: Juni 27-28, 2024 📍 Stand A5 📍 Ort: Kongresszentrum Kursaal Interlaken, Schweiz 🔔 Folgen Sie uns für Updates und Live-Berichterstattung vom SGGG-Jahreskongress der Schweizer Gynäkologie. Wir freuen uns, Sie dort zu sehen.  Rejoignez-nous sur notre stand A5 pour échanger avec notre équipe, Julien FINCI et Ikram Guerd, lors de la conférence suisse de la SGGG les 27 et 28 juin ! Préparez-vous à des démonstrations en direct, à des compétitions sur simulateurs et à un aperçu de l'avenir de la gynécologie ! 🚀 🏆 Compétition sur le stand et accès aux simulateurs : Arrêtez-vous sur notre stand pour participer à une compétition pratique amicale pour maîtriser le #Carevix™ à l'aide de simulateurs, offrant des opportunités d'apprentissage interactives et avoir une chance d'obtenir un prix. 📅 Date : 27-28 juin 2024 📍 Stand A5 📍 Emplacement : Centre de congrès Kursaal Interlaken, Suisse. 🔔 Suivez-nous pour des mises à jour et une couverture en direct du Congrès annuel de gynécologie suisse SGGG. Nous nous réjouissons de vous y retrouver.  #Aspivix #SGGG2024 #InnovationInHealthcare #Carevix #IUS #womenshealth #gynecology

Aspivix selected to pitch for the innovation competition at the 12th edition of Medi'nov Spain on June 26, 2024! 🌟 Our VP of Global Marketing, Ikram Guerd, will represent Aspivix, at this key #MedTech event. This is the perfect opportunity to showcase our next-generation cervical stabilizer #Carevix™, clinically proven to significantly reduce pain and bleeding during #IUD and other transcervical procedures. 📆 Date: June 26 📍Location: World Trade Center - Barcelona ℹ️ More info: https://lnkd.in/dxkpEjYz Stay tuned for more updates and wish her luck! 🤞 #InnovationShowcase #MedTech #MediNovSpain #Aspivix #Innovation #iud #womenshealth #femtech #femmedtech #health #femhealth #transcervical #aspivix #carevix Julien FINCI David Finci Mathieu Horras

Want to engage with a Swiss leading expert on new groundbreaking research focused on worldwide patients' and users' experiences with #carevix? 📊 𝗖𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗮 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗲𝘅𝗽𝗲𝗿𝘁: Dive deeper into the latest research in #gynecology focused on the current standard of care using the cervical #tenaculum and solution for pain reduction with recent real-world data. 🔍 Meet Dr. Michal Yaron, head of the gynecological outpatient unit at the Geneva University Hospitals (HUG - Hopitaux Universitaires de Genève), on 𝗝𝘂𝗻𝗲 𝟮𝟳 for one of the 3 dedicated time slots of 15 min. 𝗕𝗼𝗼𝘁𝗵 𝗔𝟱 to gain insights into groundbreaking research. 🗣 Ask any questions related to her latest study and abstract recently presented at ACOG: “Story of the past - Painful Gynecological Procedures”. 🩺✨ 📅 Date: June 27, 2024 🕒 3 Time Slots: 10.00 AM | 11.30 AM | 3.30 PM CET 📍 Booth A5 📍 Location: KURSAAL, INTERLAKEN Look forward to meeting you in booth A5 for clinical discussions at SGGG Swiss Conference! #Aspivix #SGGG2024 #HealthcareInnovation #ExpertTalks #ResearchInsights #carevix American College of Obstetricians and Gynecologists (ACOG)

🌟 Women will (finally) have better access to healthcare! 🌟 Héloïse Rambert's recent article for Le Point sheds light on the remarkable innovations reshaping women's healthcare. From cutting-edge advancements in endometriosis diagnosis to pioneering non-hormonal treatments for menopause, the medical community is increasingly prioritizing women's unique health needs. 🚺 But this isn't just about medical advancements—it signifies a fundamental shift towards prioritizing women's health globally when we know that: 💵 the health gender gap costs globally $1B/year (World Economic Forum) 💉 women are diagnosed too late vs men for 700 different diseases Political initiatives, societal changes, and economic motivations becoming a key driver are converging to bridge the gap in healthcare access and innovation. 📈 FemTech global market: The "market" to be From $51B in 2021 to a $103B projection for 2030, without taking into account that every year that growth exceeds expectations and diversification leading to expansion of the business. In 2024, with the rise of FemTech, innovations and significant investments in the women's health, the future looks bright. So, who wants to join the movement? ♀ 🔗 If you're curious, read the full article here: https://lnkd.in/ehCngfFS ---------------------------------------------------------------- 🌟 Les femmes auront (enfin) un meilleur accès aux soins ! 🌟 Le récent article d'Héloïse Rambert pour Le Point met en lumière les innovations remarquables qui remodèlent la santé des femmes. Des progrès de pointe dans le diagnostic de l'endométriose aux traitements non hormonaux novateurs pour la ménopause, la communauté médicale donne de plus en plus la priorité aux besoins de santé uniques des femmes. 🚺 Mais il ne s’agit pas seulement de progrès médicaux : cela signifie un changement fondamental vers une priorité accordée à la santé des femmes à l’échelle mondiale lorsque nous savons que : 💵 L’écart entre les sexes en matière de santé coûte globalement 1 milliard de dollars/an 💉 Diagnostic tardif des femmes par rapport aux hommes pour 700 maladies différentes Les initiatives politiques, les changements sociétaux et les motivations économiques, devenues des moteurs clés, convergent pour combler le fossé en matière d’accès aux soins de santé et d’innovation. 📈 Marché mondial FemTech en forte croissance De 51 milliards de dollars en 2021 à une projection de 103 milliards de dollars pour 2030, sans tenir compte du fait que chaque année, cette croissance dépasse les attentes et la diversification conduisant à l'expansion du secteur. En 2024, avec l’essor de la #FemTech, les innovations et les investissements importants dans la santé des femmes, l’avenir s’annonce prometteur. Qui veut rejoindre le mouvement ? ♀ Juliette Mauro Femtech France Caroline DE PAUW Delphine Moulu #womenshealth